✦ LIBER ✦

The CUE debate (continued): on surrogate tests and surrogate endpoints

✍ Scribed by M.P. Busch; H.A. Perkins; P. Holland; L. Petersen

Book ID: 114439284
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 132 KB
Volume: 31
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1991.31992094677.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Testing the effectiveness of discrete an

Testing the effectiveness of discrete and continuous environmental diversity as a surrogate for species diversity

✍ Joaquín Hortal; Miguel B. Araújo; Jorge M. Lobo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Development and validation of a new mode

Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs

✍ J. M. GIRAUDEL; A. DIQUELOU; P. LEES; P. L. TOUTAIN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Prentice's Approach and the Meta-Analyti

Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints

✍ Ariel Alonso; Geert Molenberghs; Tomasz Burzykowski; Didier Renard; Helena Geys; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

PMDH3: THE USE OF SURROGATE ENDPOINT DAT

PMDH3: THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY: IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME

✍ R Lopert; SR Hill; DA Henry 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Tumor response and progression-free surv

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer : Findings on the basis of North Central Cancer Treatment Group trials

✍ Nathan R. Foster; Yingwei Qi; Qian Shi; James E. Krook; John W. Kugler; James R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

PMC6 META-REGRESSION AS A METHOD OF IDEN

PMC6 META-REGRESSION AS A METHOD OF IDENTIFICATION OF THE CAUSES OF HETEROGENEITY BETWEEN STUDIES ON THE EXAMPLE OF RELATIONSHIP BETWEEN SURROGATES AND CLINICALLY IMPORTANT ENDPOINTS IN TYPE—2 DIABETES MELLITUS

✍ A Marcisz; P Rys; A Wieczorek; R Plisko; M Wladysiuk; I Skrzekowska-Baran 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB